OTC Advertisements In France To Carry COVID Warnings
Executive Summary
French advertisements for OTC drugs that treat symptoms which could be associated with COVID-19 are set to carry new warning statements following a recommendation by the country's medicines regulator.
You may also be interested in...
NSAID Use By COVID Patients Not Associated With Adverse Outcomes Or Mortality – Danish Study
Study of almost 10,000 COVID-19 patients finds use of ibuprofen and other NSAIDs does not increase chance of being hospitalized, admitted to the intensive care unit, or dying.
COVID-19 Mentions Prohibited From Supplement Ads - UK Regulator
Dietary supplement ads should not make any explicit or implicit references to COVID-19, with immunity boosting claims also strictly off limits, says UK regulator the Advertising Standards Authority.
French Experts Call For Mass Vitamin D Supplementation To Fight COVID-19
With around half the French population vitamin D deficient, a group of medical experts say mass supplementation is a low cost and low risk intervention which could save lives and curb the spread of COVID-19.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: